BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36317389)

  • 1. The importance of mitosis ≥2 in selecting patients with T1 cutaneous melanomas for sentinel lymph node biopsy.
    Borgognoni L; Crocetti E; Sestini S; Brandani P; Giannotti V; Gerlini G
    Melanoma Res; 2022 Dec; 32(6):469-476. PubMed ID: 36317389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
    Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
    Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More sentinel lymph node biopsies for thin melanomas after transition to AJCC 8th edition do not increase positivity rate: A Danish population-based study of 7148 patients.
    Weitemeyer MB; Helvind NM; Brinck AM; Hölmich LR; Chakera AH
    J Surg Oncol; 2022 Mar; 125(3):498-508. PubMed ID: 34672372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
    Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
    J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How does the mitotic index impact patients with T1 melanoma? Comparison between the 7th and 8th edition of the American Joint Committee on Cancer melanoma staging system.
    Antonialli AZ; Bertolli E; de Macedo MP; Pinto CAL; Calsavara VF; Neto JPD
    An Bras Dermatol; 2020; 95(6):691-695. PubMed ID: 33008658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A retrospective, multicenter analysis of the predictive value of mitotic rate for sentinel lymph node (SLN) positivity in thin melanomas.
    Wat H; Senthilselvan A; Salopek TG
    J Am Acad Dermatol; 2016 Jan; 74(1):94-101. PubMed ID: 26542815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel node biopsy should be offered in thin melanoma with mitotic rate greater than one.
    Sekula-Gibbs SA; Shearer MA
    Dermatol Surg; 2011 Aug; 37(8):1080-8. PubMed ID: 21635622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotic rate for thin melanomas: should a single mitotic figure warrant a sentinel lymph node biopsy?
    Kirkland EB; Zitelli JA
    Dermatol Surg; 2014 Sep; 40(9):937-45. PubMed ID: 25072127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Mitotic Rate Predicts Sentinel Lymph Node Involvement in Thin Melanomas.
    Skochdopole AJ; Kutlu OC; Engelhardt KE; Lancaster WP; Abbott AM; Camp ER
    J Surg Res; 2020 Dec; 256():198-205. PubMed ID: 32711176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.
    Vaquerano J; Kraybill WG; Driscoll DL; Cheney R; Kane JM
    Ann Surg Oncol; 2006 Feb; 13(2):198-204. PubMed ID: 16418885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
    Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
    Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Melanoma Nodal Positivity and Biopsy Rates Before and After Implementation of the 7th Edition of the AJCC Cancer Staging Manual.
    Isom C; Wheless L; Hooks MA; Kauffmann RM
    JAMA Dermatol; 2019 May; 155(5):572-577. PubMed ID: 30840034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the 2009 (7th edition) AJCC melanoma staging system in the classification of thin cutaneous melanomas.
    Chu VH; Tetzlaff MT; Torres-Cabala CA; Prieto VG; Bassett R; Gershenwald JE; McLemore MS; Ivan D; Wang WL; Ross MI; Curry JL
    Biomed Res Int; 2013; 2013():898719. PubMed ID: 24369020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A nomogram to predict node positivity in patients with thin melanomas helps inform shared patient decision making.
    Friedman C; Lyon M; Torphy RJ; Thieu D; Hosokawa P; Gonzalez R; Lewis KD; Medina TM; Rioth MJ; Robinson WA; Kounalakis N; McCarter MD; Gleisner AL
    J Surg Oncol; 2019 Dec; 120(7):1276-1283. PubMed ID: 31602665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
    Isaksson K; Nielsen K; Mikiver R; Nieweg OE; Scolyer RA; Thompson JF; Ingvar C
    J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel node biopsy is indicated for thin melanomas ≥0.76 mm.
    Han D; Yu D; Zhao X; Marzban SS; Messina JL; Gonzalez RJ; Cruse CW; Sarnaik AA; Puleo C; Sondak VK; Zager JS
    Ann Surg Oncol; 2012 Oct; 19(11):3335-42. PubMed ID: 22766986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of Sentinel Lymph Node Metastasis in Patients with Thin Melanoma: An International Multi-institutional Collaboration.
    Walker RJB; Look Hong NJ; Moncrieff M; van Akkooi ACJ; Jost E; Nessim C; van Houdt WJ; Stahlie EHA; Seo C; Quan ML; McKinnon JG; Wright FC; Mavros MN
    Ann Surg Oncol; 2022 Oct; 29(11):7010-7017. PubMed ID: 35676603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 10-year, single-institution analysis of clinicopathologic features and sentinel lymph node biopsy in thin melanomas.
    Cooper C; Wayne JD; Damstetter EM; Martini M; Gordon J; Guitart J; West DP; Nardone B; Rademaker A; Gerami P
    J Am Acad Dermatol; 2013 Nov; 69(5):693-699. PubMed ID: 23978604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel Lymph Node Biopsy Positivity in Patients With Acral Lentiginous and Other Subtypes of Cutaneous Melanoma.
    Cheraghlou S; Ugwu N; Girardi M
    JAMA Dermatol; 2022 Jan; 158(1):51-58. PubMed ID: 34878492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy.
    Bartlett EK; Gimotty PA; Sinnamon AJ; Wachtel H; Roses RE; Schuchter L; Xu X; Elder DE; Ming M; Elenitsas R; Guerry D; Kelz RR; Czerniecki BJ; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2014 Feb; 21(2):643-9. PubMed ID: 24121883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.